Leonteq Securities’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$37.2K Buy
+30,746
New +$42.1K ﹤0.01% 832

Other funds holding CHRS

Leonteq Securities's CHRS Position: Q3 2026 in Review

Leonteq Securities opened a new position in Coherus Oncology (CHRS) in Q3 2026: 30,746 shares worth $37.2K. The stake represents ﹤0.01% of the portfolio and ranks #832 among its holdings.

100 funds tracked by Wall St. Rank hold CHRS as of Q3 2026.

  • Leonteq Securities held 30,746 shares of Coherus Oncology worth $37.2K as of Q3 2026.
  • Coherus Oncology was a new Leonteq Securities position in Q3 2026.
  • Coherus Oncology made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #832 holding.
  • 100 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.